CEFTAZIDIME News
CEFTAZIDIME currently has 0 news articles, with 25 predicted indications.
This page combines the AI-predicted indications for CEFTAZIDIME with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (25):
- bacterial arthritis (99.0%)
- escherichia coli infection (99.0%)
- bacterial pneumonia (99.0%)
- peritonitis (99.0%)
- meningococcal infection (99.0%)
- streptococcal pneumonia (99.0%)
- endometritis (99.0%)
- rhinoscleroma (99.0%)
- streptococcal infection (99.0%)
- viral meningitis (99.0%)
- bacterial meningitis (99.0%)
- arthropathy (99.0%)
- staphylococcal infection (99.0%)
- staphylococcus aureus infection (99.0%)
- staphylococcal pneumonia (99.0%)
- polyclonal hyperviscosity syndrome (99.5%)
- hyperamylasemia (99.5%)
- congenital analbuminemia (99.5%)
- urinary tract infection (disease) (99.4%)
- epiglottitis (99.4%)
- Ureaplasma urethritis (99.3%)
- gonococcal urethritis (99.3%)
- blood group incompatibility (99.3%)
- infectious otitis media (99.2%)
- Peptostreptococcus infectious disease (99.2%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.